 | • レポートコード：MRC-IM30658 • 出版社/出版日：IMARC / 2023年2月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2022年285億ドルであった世界の治療用ワクチン市場規模が2028年には514億ドルに達し、予測期間中（2023年-2028年）、年平均10.4％成長すると予測しています。当調査資料では、治療用ワクチンの世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（抗原ワクチン、樹状細胞ワクチン、DNAワクチン、腫瘍細胞ワクチン）分析、疾患別（自己免疫疾患ワクチン、中毒ワクチン、神経疾患ワクチン、感染症ワクチン、その他）分析、技術別（自己免疫型ワクチン、同種ワクチン）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、アジア、欧州、中南米、中東/アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、Agenus Inc.、Argos Therapeutics Inc.、Bavarian Nordic A/S、Cel-Sci Corporation、CSL Limited、Emergent Biosolutions Inc.、GSK plc、Merck & Co. Inc.、Pfizer Inc. and Sanofi S.Aなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の治療用ワクチン市場規模：種類別 - 抗原ワクチンの市場規模 - 樹状細胞ワクチンの市場規模 - DNAワクチンの市場規模 - 腫瘍細胞ワクチンの市場規模 ・世界の治療用ワクチン市場規模：疾患別 - 自己免疫疾患ワクチンの市場規模 - 中毒ワクチンの市場規模 - 神経疾患ワクチンの市場規模 - 感染症ワクチンの市場規模 - その他疾患の市場規模 ・世界の治療用ワクチン市場規模：技術別 - 自己免疫型ワクチンの市場規模 - 同種ワクチンの市場規模 ・世界の治療用ワクチン市場規模：流通チャネル別 - 病院薬局の市場規模 - 小売薬局の市場規模 - オンライン薬局の市場規模 ・世界の治療用ワクチン市場規模：地域別 - 北米の治療用ワクチン市場規模 - アジアの治療用ワクチン市場規模 - 欧州の治療用ワクチン市場規模 - 中南米の治療用ワクチン市場規模 - 中東/アフリカの治療用ワクチン市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global therapeutic vaccines market size reached US$ 28.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 51.4 Billion by 2028, exhibiting a growth rate (CAGR) of 10.4% during 2023-2028.
Therapeutic vaccines are a range of biological medications designed to stimulate or trigger the adaptive immune system to prevent disease-causing organisms and infections. They can be modified based on various applications and needs for treating different disorders, including cancer, human immunodeficiency virus (HIV) infections, and Alzheimer’s. Therapeutic vaccines aid in creating antibodies for protecting the body against pathogens, recognizing viruses or cancerous cells, reducing the viral set point in infected patients, and providing better clinical outcomes. Along with this, they are cost-effective, easy to use, and can treat late-stage diseases; thus, it is extensively used in clinical laboratories, hospitals, and vaccination centers for immunization. Currently, they are available in autoimmune, cancer, infectious and neurological disease vaccination types.
Therapeutic Vaccines Market Trends:
The increasing prevalence of various chronic ailments and the growing need for effective biologic medications for specific and targeted responses are primarily driving the therapeutic vaccines market growth. In line with this, the implementation of numerous government initiatives promoting compulsory immunization of individuals during the COVID-19 pandemic and the ongoing funding in biopharmaceutical companies to develop viral recombinants are acting as another growth-inducing factors. Additionally, the extensive utilization of morphogenesis gene therapy with exosome-mediated delivery technology for the advent of patient-specific vaccines to deal with varying cancer types is impelling the market growth. This is further supported by the escalating uptake of genetic engineering, the availability of quick deployment vaccines, and the introduction of faster drug development solutions to improve medicine designs. Apart from this, rapid enhancements in the healthcare sector, fueling consumer awareness regarding the accessibility to several therapeutic drugs, and ongoing research and development (R&D) activities to enhance product effectiveness are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global therapeutic vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, disease type, technology and distribution channel.
Breakup by Type:
Antigen Vaccines
Dendritic Cell Vaccine
DNA Vaccine
Tumor Cell Vaccines
Breakup by Disease Type:
Autoimmune Disease Vaccines
Addiction Vaccine
Neurological Disease Vaccine
Infectious Disease Vaccine
Others
Breakup by Technology:
Autologous Vaccines
Allogeneic Vaccine
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agenus Inc., Argos Therapeutics Inc., Bavarian Nordic A/S, Cel-Sci Corporation, CSL Limited, Emergent Biosolutions Inc., GSK plc, Merck & Co. Inc., Pfizer Inc. and Sanofi S.A.
Key Questions Answered in This Report
1. What was the size of the global therapeutic vaccines market in 2022?
2. What is the expected growth rate of the global therapeutic vaccines market during 2023-2028?
3. What are the key factors driving the global therapeutic vaccines market?
4. What has been the impact of COVID-19 on the global therapeutic vaccines market?
5. What is the breakup of the global therapeutic vaccines market based on the type?
6. What is the breakup of the global therapeutic vaccines market based on the disease type?
7. What is the breakup of the global therapeutic vaccines market based on the technology?
8. What are the key regions in the global therapeutic vaccines market?
9. Who are the key players/companies in the global therapeutic vaccines market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Therapeutic Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Antigen Vaccines
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Dendritic Cell Vaccine
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 DNA Vaccine
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Tumor Cell Vaccines
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Disease Type
7.1 Autoimmune Disease Vaccines
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Addiction Vaccine
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurological Disease Vaccine
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Infectious Disease Vaccine
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Technology
8.1 Autologous Vaccines
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Allogeneic Vaccine
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agenus Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Argos Therapeutics Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Bavarian Nordic A/S
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Cel-Sci Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 CSL Limited
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Emergent Biosolutions Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 GSK plc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Merck & Co. Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
Figure 2: Global: Therapeutic Vaccines Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Therapeutic Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Therapeutic Vaccines Market: Breakup by Type (in %), 2022
Figure 5: Global: Therapeutic Vaccines Market: Breakup by Disease Type (in %), 2022
Figure 6: Global: Therapeutic Vaccines Market: Breakup by Technology (in %), 2022
Figure 7: Global: Therapeutic Vaccines Market: Breakup by Distribution Channel (in %), 2022
Figure 8: Global: Therapeutic Vaccines Market: Breakup by Region (in %), 2022
Figure 9: Global: Therapeutic Vaccines (Antigen Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Therapeutic Vaccines (Antigen Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Therapeutic Vaccines (Dendritic Cell Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Therapeutic Vaccines (Dendritic Cell Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Therapeutic Vaccines (DNA Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Therapeutic Vaccines (DNA Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Therapeutic Vaccines (Tumor Cell Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Therapeutic Vaccines (Tumor Cell Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Therapeutic Vaccines (Autoimmune Disease Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Therapeutic Vaccines (Autoimmune Disease Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Therapeutic Vaccines (Addiction Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Therapeutic Vaccines (Addiction Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Therapeutic Vaccines (Neurological Disease Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Therapeutic Vaccines (Neurological Disease Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Therapeutic Vaccines (Infectious Disease Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Therapeutic Vaccines (Infectious Disease Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Therapeutic Vaccines (Other Disease Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Therapeutic Vaccines (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Therapeutic Vaccines (Autologous Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Therapeutic Vaccines (Autologous Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Therapeutic Vaccines (Allogeneic Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Therapeutic Vaccines (Allogeneic Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Therapeutic Vaccines (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Therapeutic Vaccines (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Therapeutic Vaccines (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Therapeutic Vaccines (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Therapeutic Vaccines (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Therapeutic Vaccines (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: United States: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: United States: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Canada: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Canada: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Asia-Pacific: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Asia-Pacific: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: China: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: China: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Japan: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Japan: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: India: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: India: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: South Korea: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: South Korea: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Australia: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Australia: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Indonesia: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Indonesia: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Europe: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Europe: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Germany: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Germany: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: France: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: France: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: United Kingdom: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: United Kingdom: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Italy: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Italy: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Spain: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Spain: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Russia: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Russia: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Latin America: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Latin America: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Brazil: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Brazil: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Mexico: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Mexico: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Middle East and Africa: Therapeutic Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Middle East and Africa: Therapeutic Vaccines Market: Breakup by Country (in %), 2022
Figure 85: Middle East and Africa: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Global: Therapeutic Vaccines Industry: SWOT Analysis
Figure 87: Global: Therapeutic Vaccines Industry: Value Chain Analysis
Figure 88: Global: Therapeutic Vaccines Industry: Porter's Five Forces Analysis
• 日本語訳：治療用ワクチンの世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30658 ▷ お問い合わせ（見積依頼・ご注文・質問）